Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy (Q31757896)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 July 2017

Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy (English)

1 reference

Europe PubMed Central

3 July 2017

0 references

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A J Cowley

1

1 reference

Europe PubMed Central

3 July 2017

B L Wiens

2

1 reference

Europe PubMed Central

3 July 2017

R Segal

3

1 reference

Europe PubMed Central

3 July 2017

M W Rich

4

1 reference

Europe PubMed Central

3 July 2017

N C Santanello

5

1 reference

Europe PubMed Central

3 July 2017

E J Dasbach

6

1 reference

Europe PubMed Central

3 July 2017

B Pitt

7

1 reference

Europe PubMed Central

3 July 2017

ELITE Investigators. Evaluation of Losartan in the Elderly

8

1 reference

Europe PubMed Central

3 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2000

1 reference

Europe PubMed Central

3 July 2017

Quality of Life Research

1 reference

Europe PubMed Central

3 July 2017

9

1 reference

Europe PubMed Central

3 July 2017

4

1 reference

Europe PubMed Central

3 July 2017

377-384

1 reference

Europe PubMed Central

3 July 2017

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testing for treatment differences with dropouts present in clinical trials--a composite approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of ACE inhibitor therapy on quality of life in patients with heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II receptors and angiotensin II receptor antagonists.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life with ACE inhibitors in chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of enoximone on quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ACE inhibitors on the quality of life of patients with heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluating Health-related quality-of-life outcomes in patients with congestive heart failure. A review of recent randomised controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bradykinin-mediated effects of ACE inhibition.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post marketing surveillance of captopril (for hypertension): a preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Including deaths when measuring health status over time

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11131930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1008948930206

1 reference

Europe PubMed Central

3 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

3 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31757896&oldid=1866191357"